Navigation Links
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology's CYT003 for the Treatment of Allergic Asthma
Date:3/12/2013

ZURICH, March 13, 2013 /PRNewswire/ --

Cytos Biotechnology Ltd (SIX:CYTN) today announced the publication of the results from its phase 2a clinical trial with CYT003-QbG10 (CYT003), a first-in-class immune modulator in clinical development as a potential new treatment for allergic asthma. The data are published in the March issue of The Journal of Allergy and Clinical Immunology (JACI) in the article entitled "The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma" by Kai-Michael Beeh , MD, et al. (J Allergy Clin Immunol. 2013 Mar;131(3):866-874).

The article was selected for comment by the JACI Editors ("The Editors' Choice") under the heading "Get the balance right - therapeutic immune modulation in patients with allergic asthma" (J Allergy Clin Immunol. 2013 Mar; 131 (3):683).

The published study is a randomized, double-blind, placebo-controlled trial in patients with persistent allergic asthma requiring long-term treatment with inhaled corticosteroids (ICS). The study took place at five centers in Germany and recruited 63 patients who received 7 weekly to bi-weekly subcutaneous injections, with efficacy assessment during 12 weeks. ICS treatment was withdrawn in two steps from 100% to 50% to 0%. Clinical endpoints included asthma control determined by a validated questionnaire (ACQ), lung function objectively assessed by spirometry (FEV1), day and night-time asthma symptoms and use of relief medication. In addition inflammatory markers (exhaled nitric oxide and eosinophils in the peripheral blood) were evaluated. The study met all clinical endpoints. In patients treated with CYT003 their asthma control improved despite ICS withdrawal. In patients on placebo, the withdrawal of ICS, as expected, led to a worsening of the disease with a statistically significant and clinically important difference between treatment
'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. 2012-2013 Michael E. DeBakey Journalism Awards Call for Entries
2. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
3. Elsevier Announces the Launch of a New Journal: Methods in Oceanography
4. Glencoe Software Announces Extensive Design, Usability and Data DOI Upgrades for The Journal of Cell Biologys JCB DataViewer.
5. Infinata's BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists
6. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
7. Officials Find Bed Bugs in Wall Street Journal; Spray For Bed Bugs Offers Advice How to Safely Counter Possible Bed Bug Comeback
8. Major Diabetes Peer-Review Journal Publishes Postive Results Of Ultradian Diagnostics Human Pilot Study
9. American Journal of Infection Control Study Validates ATP Testing for Monitoring Sanitation in Hospitals; Charm Sciences Test Verified
10. Springer to publish new open access journal with the Korean Society for Micro and Nano Systems
11. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Texas (PRWEB) September 23, 2014 ... the current state of the Phenolic Resin industry ... overview of the industry, including definitions, applications and ... domestic market analysis are provided with a focus ... the market. A comparison between the international and ...
(Date:9/23/2014)... 2014 Research and Markets  has ... for Research and IVD Applications (Mass Spectrometry, Chromatography, ... their offering. This report defines ... in their research use and in IVD.  Proteomics ... of the structure and function of proteins. This ...
(Date:9/23/2014)... September 23, 2014 Proove Biosciences ... presented industry leading research and data on the association ... the American Academy of Pain Management’ s ... Phoenix, Arizona at the , Proove Biosciences ... gender and genetic predisposition to opioid misuse risk in ...
(Date:9/23/2014)... , Sept. 23, 2014  Age Defying Dermatology ... Noodleman , has become one of the first clinics ... only "picoseconds" aesthetic laser for tattoo removal. The treatment ... better results. "For years, tattoo removal has been a ... Dr. Noodleman. "This is an opportunity to erase tattoo ...
Breaking Biology Technology:Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2
... DURHAM, N.C. -- Duke University and United States Army ... and diaper rash preventative can be made to produce ... Duke adjunct physics professor Henry Everitt, chemistry professor Jie ... that adding sulfur to ultra-fine powders of commonplace zinc ...
... 17 St. Joseph,s Hospital and Medical Center, Phoenix, today ... Clinical InfoNET videoconferencing system to connect specialist ... This program will include the Barrow Neurological Institute, as ... , With the objective of ...
... Calif., Dec. 17 Senetek PLC,(OTC Bulletin Board: SNKTY), ... that target the science of healthy aging, today,announced that ... proposed at the Annual General Meeting of Shareholders held ... "We are pleased with the results of the ...
Cached Biology Technology:Duke researchers coax bright white light from unexpected source 2Duke researchers coax bright white light from unexpected source 3St. Joseph's Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians 2St. Joseph's Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians 3Senetek PLC Announces 2008 Annual General Meeting Voting Results 2
(Date:9/23/2014)... SANTA CLARA, California , 23 de ... anuncia el lanzamiento del Sistema 1290 Infinity ... serie 1200 de Infinity en su portafolio ... los técnicos, científicos y directores de laboratorio ... calidad analítica excepcional, facilidad de uso y ...
(Date:9/23/2014)... immediate welfare consequences of removing infant chimpanzees from their ... long-term impacts of this type of early life experience. ... observed 60 chimpanzees and concluded that those who were ... by humans as pets or performers are likely to ... multi-institutional research project, published today in the open-access journal ...
(Date:9/22/2014)... Chicago have shown that after a long stay in ... pathogenic microbe species remain behind in patients, intestines. The ... can become deadly when provoked by conditions that mimic ... published in mBio , the online open-access journal ... better monitoring and treatment of ICU patients who can ...
Breaking Biology News(10 mins):Agilent Technologies anuncia el lanzamiento del Sistema 1290 Infinity II LC 2Agilent Technologies anuncia el lanzamiento del Sistema 1290 Infinity II LC 3Chimpanzees raised as pets or performers suffer long-term effects on their behavior 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 3
... (FiO), the 91st Annual Meeting of the Optical Society ... San Jose, Calif., alongside Laser Science XXIII, the annual ... Science. Reporters interested in obtaining a badge to ... cmorri@osa.org . FiO RESEARCH HIGHLIGHTS ...
... Makes Tuna That Tastes Good, But These Bluefin Are ... bluefin tuna caught in the Gulf of Maine has ... University of New Hampshire have found by analyzing detailed ... Fishermans Co-op. The findings, published this week in Fishery ...
... the social habits of living cells an innovation ... help fight diseases such as cancer and diabetes. ... six countries, The Manchester Centre for Integrative Systems Biology ... research into an emerging field of science and engineering ...
Cached Biology News:Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 2Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 3Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 4Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 5Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 6Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 7Restoring sight, advances in fertility treatments and better visibility for pilots at FIO 8Condition of bluefin tuna in gulf of maine is declining 2Condition of bluefin tuna in gulf of maine is declining 3Social habits of cells may hold key to fighting diseases 2
Request Info...
... The Cetac Ultrasonic Nebulizers are available in two ... difference between these two models is that the ... to create a drier aerosol for improved detection ... detection limits for a range of elements by ...
... inhibition of RNase A-type ribonucleases Product Description: ... nonhuman origin that binds noncovalently and inactivates ... B, and C). It does not interfere ... or CL3. QIAGEN RNase Inhibitor inhibits greater ...
... is >95%\nNEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
Biology Products: